ZYN002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZYN002, covering 2025-11-05 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE) [Phase 2]